ASCO 2024 review: The benefits and barriers of biomarkers in oncology
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Biomarkers: what do we mean? – The term “biomarkers” can be broadly clustered into four categories: molecular, histologic, radiographic and physiological. –...
CRA’s Annabelle Fowler, Andreas Maos, and Tim Wilsdon co-authored original research that explores the roles and contributions of public and private investments...
Hannah Armstrong is moderating a panel during a program entitled, “Policy Solutions to Improve Access to Fertility Treatment and Optimize Patient Care” and...
Annabelle Fowler is a panelist on “Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking”...